Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB26FHMYN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,601
Award facts
- Contract value 100% obligated
- $13,601.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication with a ceiling value of $13,601.33. This firm fixed-price delivery order, which is not set-aside designated, represents a routine pharmaceutical procurement supporting federal healthcare systems. The contract was issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of medications and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement. The company's extensive contract history with the Defense Logistics Agency demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains, including diabetes medications, neurological treatments, and specialized medical supplies. This delivery order for Ozempic, a diabetes management medication, aligns with AmerisourceBergen's established role as a primary pharmaceutical supplier supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through competitively awarded contracts. Completion of this delivery order is scheduled for October 30, 2025.
Quick answers
Who was awarded contract SPE2DB26FHMYN?
SPE2DB26FHMYN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FHMYN worth?
The government has obligated $13,601 on SPE2DB26FHMYN.
Is contract SPE2DB26FHMYN an order under another contract?
Yes. SPE2DB26FHMYN is a delivery order under SPE2DB24D2212, an indefinite delivery contract.
Was contract SPE2DB26FHMYN competed?
The extent of competition for SPE2DB26FHMYN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award